Alkem Laboratories Limited (ALKEM.NS)
Makes affordable generic medicines and vitamins sold across India and globally
5,672.50+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+15.8%
The outlook
Alkem trades at 5672.5, positioned 78% of the way through its 52-week range and above both major moving averages, reflecting upward price momentum. Analyst consensus leans Buy with an average target about 5% above the current price. The stock carries a trailing P/E of 29.4 and a bullish-leaning overall score of 72/100.
What’s behind the score
Analyst consensusBuy — 2.5 avg of 20 analysts
Price trendAbove its 50- & 200-day averages
52-week range78% of the way from its 52-week low to high
Price targetAvg target +5% vs current price
Analyst price target
~12-month · 20 analysts5,964.80average target+5.2% vs now
Now 5,672.50
Low 4,200.00High 6,890.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$678.23B
52-wk high
5,933.50
52-wk low
4,738.50
50-day avg
5,473.06
200-day avg
5,540.27
Trailing P/E
29.4